Skip to main content
Sonnet BioTherapeutics Holdings, Inc. (SONN)
Dec 2, 2025 - SONN was delisted (reason: merged into PURR)
1.260
-1.840 (-59.35%)
Inactive · Last trade price on Dec 2, 2025

SONN Revenue

Sonnet BioTherapeutics Holdings had revenue of $1.00M in the twelve months ending June 30, 2025, up 1,689.52% year-over-year. In the fiscal year ending September 30, 2024, Sonnet BioTherapeutics Holdings had annual revenue of $18.63K, down -87.40%.

Revenue (ttm)
$1.00M
Revenue Growth
+1,689.52%
P/S Ratio
3.41
Revenue / Employee
$76,923
Employees
13
Market Cap
8.60M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 202418.63K-129.18K-87.40%
Sep 30, 2023147.81K-202.14K-57.76%
Sep 30, 2022349.94K-133.68K-27.64%
Sep 30, 2021483.63K--
Sep 30, 2020---
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

SONN News

More News